Key Developments: Japan Tobacco Inc (2914.T)

2914.T on Tokyo Stock Exchange

19 Sep 2014
Price Change (% chg)

¥11 (+0.31%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Latest Key Developments (Source: Significant Developments)

R&I affirms Japan Tobacco Inc's rating at "AA" and announces stable outlook
Friday, 11 Jul 2014 02:00am EDT 

Japan Tobacco Inc:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA".Rating outlook stable.  Full Article

Japan Tobacco Inc acquires Zandera Ltd
Wednesday, 11 Jun 2014 06:46am EDT 

Japan Tobacco Inc:Concludes agreement to acquire all outstanding shares of Zandera Ltd.This transaction will be funded by group’s existing cash and loan facilities.  Full Article

Japan Tobacco to issue year-end dividend for FY 2014
Thursday, 24 Apr 2014 02:00am EDT 

Japan Tobacco Inc:To issue year-end dividend of 50 yen per share for fiscal year ended March 2014, to shareholders of record as of March 31.Payment date June 25.Latest dividend forecast was 46 yen per share, disclosed on April 25.  Full Article

Japan Tobacco Inc and Torii Pharmaceutical Co., Ltd launches Rio na tablets
Wednesday, 16 Apr 2014 11:08pm EDT 

Japan Tobacco Inc:Torii Pharmaceutical Co., Ltd and Japan Tobacco Inc (JT) announces that Torii would launch Rio na tablets 250mg in Japan on May 12.Says it receives manufacturing and marketing approval of this drug for the indication of the improvement of hyperphosphatemia in patients with chronic kidney disease (CKD) from the Japanese Ministry of Health, Labour and Welfare in Jan 2014.JT and Torii expect to contribute to treat hyperphosphatemia in patients with CKD, including dialysis and non-dialysis dependent CKD, through marketing Riona tablets in Japan.  Full Article

Japan Tobacco Inc changes fiscal year end
Thursday, 30 Jan 2014 01:00am EST 

Japan Tobacco Inc:Says changed fiscal year end to Dec. 31 from Mar. 31.  Full Article

Japan Tobacco Inc and Torii Pharmaceutical Co Ltd receive approval for hyperphosphatemia tablet Riona
Friday, 17 Jan 2014 02:00am EST 

Japan Tobacco Inc and Torii Pharmaceutical Co Ltd:Says received manufacturing and marketing approval of Riona Tablets 250mg, which is jointly developed by the two companies, from the Japanese Ministry of Health, Labour and Welfare.Says the drug is indicated as an oral treatment for the improvement of hyperphosphatemia in patients1 with chronic kidney disease (CKD).Says Riona Tablets is a novel phosphate binder containing ferric citrate hydrate as the active pharmaceutical ingredient.  Full Article

Japan Tobacco Inc to take participation in Megapolis Distribution B.V
Wednesday, 4 Dec 2013 07:00am EST 

Japan Tobacco Inc:Says entered into an agreement to acquire a 20 pct stake in Megapolis Distribution B.V., a holding company of CJSC TK Megapolis (Megapolis).Says the acquisition is expected to be completed by Dec. 31.Says Megapolis accounts for 70 pct of Russian cigarette distribution market and the acquisition will strengthen the long term relationship between the company and Megapolis.Says cash consideration for the transaction is $750 million, which excludes an additional component of up to $ 100 million which is subject to Megapolis’ operational performance over the four fiscal years following the closing of this transaction.  Full Article

Japan Tobacco Inc Announces Elvitegravir (JTK-303) Receives EU regulatory Approval
Tuesday, 19 Nov 2013 01:00am EST 

Japan Tobacco Inc announced that a novel HIV integrase inhibitor, the Company's original compound elvitegravir (JTK-303), has been approved by the European Medicines Agency (EMA). The drug is to be marketed as Vitekta in the European Union. Japan Tobacco Inc. The Company announced that a statement has been issued to this effect by Gilead Sciences, Inc. (Gilead) of Foster City, California, to which the Company licensed elvitegravir in March 2005 with exclusive rights to develop and commercialize the drug worldwide, excluding Japan.  Full Article

Japan Tobacco Inc Announces Restructuring of Tobacco Business
Wednesday, 30 Oct 2013 02:00am EDT 

Japan Tobacco Inc announced that it will reduce sub-branches from 25 sub-branches to 15 sub-branches effective April 1, 2015. The Company will also close several factories and business centers by the end of March 2015. The Company will offer an early-retirement program along with the business restructuring. The Company expects 1,600 employees to take up the offer.  Full Article

Nippon Commercial Development Co Ltd's Subsidiary Acquires Land from Japan Tobacco Inc
Thursday, 26 Sep 2013 03:00am EDT 

Nippon Commercial Development Co Ltd announced that its wholly owned subsidiary has completed the acquisition of a plot of land located in Tokyo, with an area of 3,190.24 square meters, from Japan Tobacco Inc. The transaction price is not disclosed.  Full Article

REFILE-Japan Tobacco not planning M&A in e-cigarette business now - CEO

TOKYO, Aug 25 - Japan Tobacco Inc is currently not interested in further acquisitions of vaporisers or electronic cigarette brands, its president said on Monday.

Search Stocks